Inventiva Sa Stock Fundamentals
| IVA Stock | USD 2.16 0.05 2.37% |
Inventiva Sa fundamentals help investors to digest information that contributes to Inventiva's financial success or failures. It also enables traders to predict the movement of Inventiva Stock. The fundamental analysis module provides a way to measure Inventiva's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Inventiva stock.
Inventiva |
Inventiva Sa Company Operating Margin Analysis
Inventiva's Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current Inventiva Operating Margin | (19.11) % |
Most of Inventiva's fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Inventiva Sa is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
| Competition |
Based on the recorded statements, Inventiva Sa has an Operating Margin of -19.1108%. This is 45.52% lower than that of the Biotechnology sector and 82.95% lower than that of the Health Care industry. The operating margin for all United States stocks is notably higher than that of the company.
Inventiva Sa Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Inventiva's current stock value. Our valuation model uses many indicators to compare Inventiva value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Inventiva competition to find correlations between indicators driving Inventiva's intrinsic value. More Info.Inventiva Sa is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Inventiva's earnings, one of the primary drivers of an investment's value.Inventiva Operating Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Inventiva's direct or indirect competition against its Operating Margin to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Inventiva could also be used in its relative valuation, which is a method of valuing Inventiva by comparing valuation metrics of similar companies.Inventiva is currently under evaluation in operating margin category among its peers.
Inventiva Fundamentals
| Return On Equity | -16.43 | ||||
| Return On Asset | -1.13 | ||||
| Operating Margin | (19.11) % | ||||
| Current Valuation | 157.95 M | ||||
| Shares Outstanding | 52.36 M | ||||
| Shares Owned By Institutions | 9.24 % | ||||
| Number Of Shares Shorted | 350.68 K | ||||
| Price To Book | 2.10 X | ||||
| Price To Sales | 10.82 X | ||||
| Revenue | 17.48 M | ||||
| Gross Profit | 18.81 M | ||||
| EBITDA | (102.04 M) | ||||
| Net Income | (110.43 M) | ||||
| Cash And Equivalents | 76.72 M | ||||
| Cash Per Share | 1.82 X | ||||
| Total Debt | 37.49 M | ||||
| Debt To Equity | 0.27 % | ||||
| Current Ratio | 4.16 X | ||||
| Book Value Per Share | (1.51) X | ||||
| Cash Flow From Operations | (81.61 M) | ||||
| Short Ratio | 1.59 X | ||||
| Earnings Per Share | (2.14) X | ||||
| Number Of Employees | 123 | ||||
| Beta | 0.81 | ||||
| Market Capitalization | 229.75 M | ||||
| Total Asset | 69.56 M | ||||
| Retained Earnings | (110.43 M) | ||||
| Working Capital | (1.97 M) | ||||
| Net Asset | 69.56 M |
About Inventiva Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Inventiva Sa's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Inventiva using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Inventiva Sa based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Inventiva S.A., a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis , mucopolysaccharidoses , and other diseases. Inventiva S.A. was founded in 2011 and is based in Daix, France. Inventiva is traded on NASDAQ Exchange in the United States.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| BTC | Bitcoin | |
| TRX | TRON | |
| BNB | Binance Coin |
Check out Inventiva Piotroski F Score and Inventiva Altman Z Score analysis. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Inventiva. If investors know Inventiva will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Inventiva listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Inventiva Sa is measured differently than its book value, which is the value of Inventiva that is recorded on the company's balance sheet. Investors also form their own opinion of Inventiva's value that differs from its market value or its book value, called intrinsic value, which is Inventiva's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Inventiva's market value can be influenced by many factors that don't directly affect Inventiva's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Inventiva's value and its price as these two are different measures arrived at by different means. Investors typically determine if Inventiva is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Inventiva's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.